Association of Rising Cost and Use of Oral Anticancer Drugs With Medicare Part D Spending From 2013 Through 2017.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 31697307.
- Also identified by DOI 10.1001/jamaoncol.2019.4906 and PMC identifier 6865225.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This cross-sectional study weighs the proportional associations of rising drug costs and use with increased Medicare Part D spending for a cohort of oral anticancer drugs used from 2013 through 2017.
Medical subject headings
- Antineoplastic Agents
- Medicare Part D
- Prescription Drugs